FOLLICULAR LYMPHOMA WITH UNUSUAL CYTOLOGICAL FEATURES

Clinical trials for FOLLICULAR LYMPHOMA WITH UNUSUAL CYTOLOGICAL FEATURES explained in plain language.

Never miss a new study

Get alerted when new FOLLICULAR LYMPHOMA WITH UNUSUAL CYTOLOGICAL FEATURES trials appear

Sign up with your email to follow new studies for FOLLICULAR LYMPHOMA WITH UNUSUAL CYTOLOGICAL FEATURES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Head-to-Head cancer drug showdown: can new treatment outperform standard?

Disease control Recruiting now

This large study compares two antibody treatments for people with early-stage follicular lymphoma, a slow-growing blood cancer. Researchers want to see if a newer drug called mosunetuzumab keeps the cancer under control longer than the standard treatment rituximab. The trial will…

Matched conditions: FOLLICULAR LYMPHOMA WITH UNUSUAL CYTOLOGICAL FEATURES

Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 25, 2026 14:07 UTC

FOLLICULAR LYMPHOMA WITH UNUSUAL CYTOLOGICAL FEATURES

Get alerted when new FOLLICULAR LYMPHOMA WITH UNUSUAL CYTOLOGICAL FEATURES trials appear

Head-to-Head cancer drug showdown: can new treatment outperform standard?